TMS Co., Ltd. (4891.T)
JPY 140.0
(0.0%)
JPY 140.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -960.04 Million JPY | -11.51% |
| 2022 | -860.92 Million JPY | -179.95% |
| 2021 | 1.07 Billion JPY | 248.96% |
| 2020 | -722.93 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -247.67 Million JPY | 37.41% |
| 2024 Q2 | -230.15 Million JPY | 7.07% |
| 2023 Q1 | -148.85 Million JPY | -38.13% |
| 2023 Q4 | -395.72 Million JPY | -78.5% |
| 2023 FY | -960.04 Million JPY | -11.51% |
| 2023 Q2 | -193.76 Million JPY | -30.17% |
| 2023 Q3 | -221.69 Million JPY | -14.41% |
| 2022 Q2 | -234 Million JPY | 0.0% |
| 2022 FY | -860.92 Million JPY | -179.95% |
| 2022 Q4 | -107.76 Million JPY | 62.19% |
| 2022 Q3 | -285 Million JPY | -21.79% |
| 2021 FY | 1.07 Billion JPY | 248.96% |
| 2020 FY | -722.93 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 350.01% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -82.201% |
| GNI Group Ltd. | 8.09 Billion JPY | 111.861% |
| Linical Co., Ltd. | 338.26 Million JPY | 383.812% |
| Trans Genic Inc. | 4.08 Million JPY | 23601.591% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 33.236% |
| Soiken Holdings Inc. | -662.2 Million JPY | -44.977% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 794.901% |
| AnGes, Inc. | -7.43 Billion JPY | 87.092% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 25.471% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 86.653% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 614.232% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -23.082% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 16.728% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 20.592% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -18.172% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -196.618% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 21.309% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 32.49% |
| PeptiDream Inc. | 3.03 Billion JPY | 131.624% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 50.475% |
| Ribomic Inc. | -1.02 Billion JPY | 6.268% |
| SanBio Company Limited | -2.64 Billion JPY | 63.69% |
| Healios K.K. | -3.82 Billion JPY | 74.888% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 17.811% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 35.551% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 32.836% |
| StemRIM | -2.02 Billion JPY | 52.52% |
| CellSource Co., Ltd. | 923.14 Million JPY | 203.997% |
| FunPep Company Limited | -933.41 Million JPY | -2.852% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -12.397% |
| Stella Pharma Corporation | -763.74 Million JPY | -25.701% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 15.042% |
| Cuorips Inc. | -632.18 Million JPY | -51.861% |
| K Pharma,Inc. | 260.33 Million JPY | 468.778% |
| Takara Bio Inc. | 1.48 Billion JPY | 164.868% |
| ReproCELL Incorporated | -31.41 Million JPY | -2955.992% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3739.548% |
| StemCell Institute Inc. | 310.98 Million JPY | 408.713% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 770.564% |
| CellSeed Inc. | -846.53 Million JPY | -13.408% |